MIM
Monashee Investment Management Portfolio holdings
AUM
$190M
This Quarter Return
+12.57%
1 Year Return
+42.84%
3 Year Return
+185.9%
5 Year Return
+237.5%
10 Year Return
+2,730.86%
AUM
$419M
AUM Growth
+$419M
(+16%)
Cap. Flow
+$118M
Cap. Flow
% of AUM
28.12%
Top 10 Holdings %
Top 10 Hldgs %
66.93%
Holding
99
New
53
Increased
2
Reduced
10
Closed
24
Top Buys
| 1 |
Structure Therapeutics
GPCR
|
$19.9M |
| 2 |
Invesco QQQ Trust
QQQ
|
$10.3M |
| 3 |
RadNet
RDNT
|
$9.79M |
| 4 |
Nextracker
NXT
|
$7.97M |
| 5 |
Casella Waste Systems
CWST
|
$7.69M |
Top Sells
| 1 |
iShares Russell 2000 ETF
IWM
|
$16.9M |
| 2 |
Alight
ALIT
|
$7.24M |
| 3 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$5.18M |
| 4 |
Viking Therapeutics
VKTX
|
$5M |
| 5 |
Biohaven
BHVN
|
$4.78M |
Sector Composition
| 1 | Healthcare | 20.13% |
| 2 | Technology | 3.56% |
| 3 | Industrials | 3.21% |
| 4 | Consumer Discretionary | 2.86% |
| 5 | Real Estate | 1.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Vanguard Total Stock Market ETF
VTI
$526B
| $165M | 39.44% | 750,000 -15,000 | -2% | -$3.3M |
|
|
2
Invesco QQQ Trust
QQQ
$364B
| $31.4M | 7.5% | 85,000 +28,000 | +49% | +$10.3M |
|
|
3
Structure Therapeutics
GPCR
$1.11B
| $22.8M | 5.43% | 1,370,991 +1,200,991 | +706% | +$19.9M |
|
|
4
RadNet
RDNT
$5.52B
| $9.79M | 2.34% | +300,000 | New | +$9.79M |
|
|
5
Nextracker
NXT
$9.95B
| $7.97M | 1.9% | +200,154 | New | +$7.97M |
|
|
6
Casella Waste Systems
CWST
$6.26B
| $7.69M | 1.84% | +85,000 | New | +$7.69M |
|
7
GE HealthCare
GEHC
$33.7B
| $7.31M | 1.75% | +90,000 | New | +$7.31M |
|
8
Compass Therapeutics
CMPX
$483M
| $6.26M | 1.49% | 1,969,296 -207,746 | -10% | -$661K |
|
9
Axsome Therapeutics
AXSM
$6.05B
| $5.39M | 1.29% | +75,000 | New | +$5.39M |
|
10
MKS Inc. Common Stock
MKSI
$6.94B
| $4.32M | 1.03% | +40,000 | New | +$4.32M |
|
11
Chart Industries
GTLS
$8.96B
| $4.31M | 1.03% | 27,000 -9,468 | -26% | -$1.51M |
|
12
Roivant Sciences
ROIV
$8.15B
| $4.03M | 0.96% | 400,000 -100,000 | -20% | -$1.01M |
|
13
argenx
ARGX
$43.6B
| $3.9M | 0.93% | 10,000 | – | – |
|
14
Mobileye
MBLY
$11.4B
| $3.84M | 0.92% | +100,000 | New | +$3.84M |
|
15
Lucid Motors
LCID
$6.08B
| $3.38M | 0.81% | +490,000 | New | +$3.38M |
|
16
Vesta Real Estate
VTMX
$2.32B
| $3.22M | 0.77% | +100,000 | New | +$3.22M |
|
17
Ryman Hospitality Properties
RHP
$6.22B
| $3.02M | 0.72% | +32,500 | New | +$3.02M |
|
18
Fidelis Insurance
FIHL
$1.83B
| $2.73M | 0.65% | +200,000 | New | +$2.73M |
|
19
MoonLake Immunotherapeutics
MLTX
$3.54B
| $2.55M | 0.61% | +50,000 | New | +$2.55M |
|
20
US Physical Therapy
USPH
$1.26B
| $2.43M | 0.58% | +20,000 | New | +$2.43M |
|
21
Day One Biopharmaceuticals
DAWN
$769M
| $2.39M | 0.57% | +199,900 | New | +$2.39M |
|
|
MOND
22
DELISTED
Mondee Holdings, Inc. Class A Common Stock
MOND
| $2.18M | 0.52% | +245,000 | New | +$2.18M |
|
23
Gulfport Energy Corp
GPOR
$3.06B
| $2.1M | 0.5% | +20,000 | New | +$2.1M |
|
24
Disc Medicine
IRON
$2.07B
| $2M | 0.48% | +45,000 | New | +$2M |
|
25
Zura Bio
ZURA
$133M
| $1.97M | 0.47% | +240,000 | New | +$1.97M |
|